Reset
Showing 20 of 873 academic articles

Protocol to evaluate sequential electronic health record-based strategies to increase genetic testing for breast and ovarian cancer risk across diverse patient populations in gynecology practices

Heather Symecko, Robert Schnoll, Rinad S. Beidas, Justin E. Bekelman et al. • Implementation Science (2023)

Abstract Background Germline genetic testing is recommended by the National Comprehensive Cancer Network (NCCN) for individuals including, but not limited to, those with a personal history of ovarian cancer, young-onset (...

DOAJ Open Access (DOAJ) DOI: 10.1186/s13012-023-01308-w

Study on PM2.5 pollution and the mortality due to lung cancer in China based on geographic weighted regression model

Qilong Cao, Guoqiang Rui, Ying Liang • BMC Public Health (2018)

Abstract Background PM2.5 has become a major component of air pollution in China and has led to a series of health problems. The mortality rate caused by lung cancer has reached the point where it cannot be ignored in China. Air pollution i...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12889-018-5844-4

The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally

Tessa Suzanne van Schooten, Sarah Derks, Elena Jiménez-Martí, Fatima Carneiro et al. • BMC Cancer (2022)

Abstract Background Gastric Cancer (GC) is the fourth most deadly cancer worldwide. Enhanced understanding of its key epidemiological and molecular drivers is urgently needed to lower the incidence and improve outcomes. Furthermore, tumor b...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12885-022-09689-9

Study of serum Total Immunoglobulin E in Egyptian patients with newly diagnosed colorectal carcinoma

Wessam Eid, Fawzia Abo Ali, Sara Taha, Sara Zaki et al. • Zagazig University Medical Journal (2022)

Total immunoglobulin E (IgE) has roles in allergy and anti-parasitic immunity. Recently IgE showed a major role in cancer immune surveillance; an increased risk of solid and blood malignancies has been associated with total IgE deficiency. ...

DOAJ Open Access (DOAJ) DOI: 10.21608/zumj.2022.130517.2541

Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors

Safwaan H. Khan, Safwaan H. Khan, Yeonjoo Choi, Mysore Veena et al. • Frontiers in Immunology (2025)

Chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of hematologic malignancies, achieving remarkable clinical success with FDA-approved therapies targeting CD19 and BCMA. However, the extension of these successe...

DOAJ Open Access (DOAJ) DOI: 10.3389/fimmu.2024.1489827

Lung cancer tumor immune microenvironment: analyzing immune escape mechanisms and exploring emerging therapeutic targets

Zhen Wang, Honglei Guo, Yanqi Song, Aidi Wang et al. • Frontiers in Immunology (2025)

Lung cancer is the most common malignant tumor in the world. Presently, there are still problems, including a high recurrence rate, resistance, and serious toxic side effects, even if conventional treatments like chemotherapy, radiotherapy,...

DOAJ Open Access (DOAJ) DOI: 10.3389/fimmu.2025.1597686

Linker-specific monoclonal antibodies present a simple and reliable detection method for scFv-based CARNK cells

Katharina Schindler, Katharina Eva Ruppel, Claudia Müller, Ulrike Koehl et al. • Molecular Therapy: Methods & Clinical Development (2024)

Chimeric antigen receptor (CAR) T cell therapies have demonstrated significant successes in treating cancer. Currently, there are six approved CAR T cell products available on the market that target different malignancies of the B cell line...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.omtm.2024.101328

Accumulation of tissue-resident natural killer cells, innate lymphoid cells, and CD8+ T cells towards the center of human lung tumors

Demi Brownlie, Andreas von Kries, Giampiero Valenzano, Nicole Wild et al. • OncoImmunology (2023)

Lung cancer is a leading cause of cancer-related death worldwide. Despite recent advances in tissue immunology, little is known about the spatial distribution of tissue-resident lymphocyte subsets in lung tumors. Using high-parameter flow c...

DOAJ Open Access (DOAJ) DOI: 10.1080/2162402X.2023.2233402

Characterization of Primate Antibody Responses to Administered Murine Monoclonal Immunoglobulin

D.E. Milenic, B. Detrick, J.C. Reynolds, D. Colcher • The International Journal of Biological Markers (1990)

Murine monoclonal antibodies (MAb) are currently being assessed for their utility as tools in cancer management. Anti-murine immunoglobulin responses have been observed in many patients receiving monoclonal antibody treatment. In this study...

DOAJ Open Access (DOAJ) DOI: 10.1177/172460089000500403

The central inflammatory regulator IκBζ: induction, regulation and physiological functions

Yanpeng Feng, Zhiyuan Chen, Yi Xu, Yuxuan Han et al. • Frontiers in Immunology (2023)

IκBζ (encoded by NFKBIZ) is the most recently identified IkappaB family protein. As an atypical member of the IkappaB protein family, NFKBIZ has been the focus of recent studies because of its role in inflammation. Specifically, it is a key...

DOAJ Open Access (DOAJ) DOI: 10.3389/fimmu.2023.1188253

Case Report: A severe case of immunosuppressant-refractory immune checkpoint inhibitor-mediated colitis rescued by tofacitinib

Mark W. D. Sweep, Mark W. D. Sweep, Martijn J. H. Tjan, Mark A. J. Gorris et al. • Frontiers in Immunology (2023)

Immune checkpoint inhibitor therapy for cancer treatment can give rise to a variety of adverse events. Here we report a male patient with metastatic melanoma who experienced life-threatening colitis and duodenitis following treatment with i...

DOAJ Open Access (DOAJ) DOI: 10.3389/fimmu.2023.1212432

Cancer Immunology

Olivera J. Finn • New England Journal of Medicine (2008)

This review is a comprehensive account of the current status of tumor immunology, beginning with the identification of human tumor antigens and ending with a summary of clinical applications of what we know about the immunology of tumors....

OPENALEX DOI: https://doi.org/10.1056/nejmra072739